Weekly CFDA News Roundup (May 6th to May 12th)

Monthly CFDA News Roundup (April)
May 9, 2018
Weekly CFDA News Roundup (May 13th to May 19th)
May 23, 2018

Weekly CFDA News Roundup (May 6th to May 12th)

Weekly CFDA News Roundup covers policies, regulations, QA/recall/AE, and new approvals in medical device and IVD in China. It is edited by China Med Device, LLC, a consulting firm specializing in China CFDA regulatory, CRO and market access services.

Policy

  1. CFDA issued “Innovative Medical Device Special Approval Procedures (Revised Draft for Feedback)”. Within 60 days after the application is received by CFDA, the agency will notify the applicant whether the application has been approved.
  2. Hainan provincial government published “Regulation for Urgently Needed Imported Medical Devices in Hainan”. Before CFDA registration approval, imported medical device can be clinically used in qualified healthcare facilities.

For English version of the above documents, please email info@ChinaMedDevice.com.

 

Guideline

CFDA issued 2 guidelines on May 11:

  • pre-clinical trial guideline on coronary drug-eluting stent
  • clinical trial guideline on coronary drug-eluting stent

 

QA/Recall/AE

CFDA announced recall notices to 5 medical devices from 4 foreign manufactures and 1 domestic one. Foreign manufacturers include:

  • GE: x-ray bone density detector
  • Becton Dickinson: vacuum blood collection tube
  • Smith & Nephew: 1) external fixation system 2) RF plasma surgery system
  • Magellan: blood lead analyzer

 

Keep yourself updated with CFDA News Roundup, click HERE to opt-in. For market access newsletter, click HERE

 

About China Med Device, LLC

China Med Device, LLC provides turn-key solutions for western medical device/IVD companies to enter China with regulation and commercialization services. Our CFDA regulatory services cover strategy, premarket submission, clinical evaluation, CRO, post market compliance as well as legal agent representation. Our commercial services cover market assessment research, reimbursement, partnership, distribution qualification and management. We have an office in Beijing, Suzhou and Boston. Our management team have 100+ years of combined experience in medical device and IVD and had been involved with 1,000+ CFDA certificates, 200+ companies’ success.